Search results for " industry" in Articles / App Notes
Article
Taking a “Development-by-Design” Approach to Cell Therapies
There is a tendency for people in the industry to ignore the product profile until they have all the answers, says Hampson. “Instead, it needs to be developed really early, even when you don’t have al…
Article
Optimization of Protein Expression in Escherichia Coli
The BL21(DE3) strain is one of the most commonly used strains in both industry and academia. It carries the phage T7 gene 1—encoding T7 RNA polymerase—in its chromosome under the control of the lacUV5…
Article
Vaccine Development and Production Challenges Manufacturers
NIH is collaborating with industry and leading scientists in Liberia to launch a large Phase II/III trial of two leading vaccine candidates from GSK and Merck with NewLink Genetics, explained Anthony …
Article
The Bullish Outlook for Biosimilars
The cost of drugs has become a focal point of popular and industry dissatisfaction in the US, in spite of the relatively modest percentage of overall healthcare costs accounted for by pharmaceuticals …
Article
Fermentation for the Future
Both academic and industry researchers are working to overcome these issues and have made notable advances in the development of engineered yeast strains.
Much of the work was accomplished in P. p…
Article
Technologies and Practices Must Evolve to Meet Demand
Nearly two-thirds of those responding believe technology will evolve to permit full continuous manufacturing in five years; however, industry adoption may lag or the technology will be applied in sele…
Article
Ligand-Binding Assays and the Determination of Biosimilarity
“High-throughput, kinetic assessment of target binding on cells for those targets that cannot be produced as soluble proteins remains a challenge for the industry,” she observes. Several companies are…
Article
High-Throughput Process Development in an Historical Environment
The purpose of the Olympiad is to allow process developers to benchmark their internal HTPD workflows against peers in the biopharmaceutical industry and academy. The challenge in the very first HTPD …
Article
A Q&A With Dr. Anurag Rathore About the Future of QbD, Part 2
Read More Q&As With Industry Leaders Here
Article
Single-Domain Antibodies for Brain Targeting
Single-domain antibodies are emerging as credible alternatives due to their target specificity, high affinity, and cost-effective recombinant production.
Smaller recombinant antibody fragments a…